Skip to main content
. 2017 Mar-Apr;21(2):341–354. doi: 10.4103/ijem.IJEM_512_16

Table 5.

Expert group recommendation 5: Dose modification of pioglitazone in chronic liver disease

graphic file with name IJEM-21-341-g007.jpg